Because it causes tissue damage and tissue death in the legs, feet, and toes, PAD is implicated in 150,000 lower-limb ...

Peripheral vascular disease (PVD) is a group of conditions involving problems with blood vessels outside your heart and brain. Peripheral arterial disease (PAD) is a type of PVD where your arteries ...

Peripheral artery disease is primarily caused by plaque buildup in your arteries, with risks increased by underlying medical conditions and certain lifestyle factors, but there’s also a possible ...

Symptoms of peripheral vascular disease (PVD) in the foot include pain, cramping, and tingling. Treatment can slow progression and includes lifestyle changes, medication, and surgery. PVD, also known ...

Peripheral Artery Disease, the narrowing of blood vessels in the legs, has exploded in prevalence. Data from the Global Burden of Disease study suggest that global PAD cases surged from roughly 66 ...

Diabetes is a risk factor for developing peripheral vascular disease (PVD). Symptoms include painful muscle cramping, slow-healing wounds, and more. Treatments and prevention steps can help prevent ...

This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being. This Collection invites primary research exploring disease mechanisms or providing insight into PAD ...

There are significant differences in the prevalence, diagnosis, treatment, and outcomes of peripheral vascular disease (PVD) between men and women, according to a statement from the American Heart ...

STATEN ISLAND, N.Y. — Staten Island University Hospital is shining a light on Peripheral Arterial Disease this fall, with a Vascular Disease Awareness Walk. Peripheral Arterial Disease (PAD) is a ...

BD is putting a fresh spin on an old awareness drive, returning to the 12-year-old “Love Your Limbs” campaign to mark Peripheral Artery Disease (PAD) Awareness Month. The company, which sells PAD ...

CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE trial, ...